158 related articles for article (PubMed ID: 30574903)
1. Response to anti-vascular endothelial growth factor of abnormal retinal vascular net in para foveal telangiectasia group II images on optical coherence tomography-angiography.
Saoji K; Pathengay A; Chhablani J; Panchal B; Doshi S; Saldanha M
Indian J Ophthalmol; 2019 Jan; 67(1):105-108. PubMed ID: 30574903
[TBL] [Abstract][Full Text] [Related]
2. Comparison of anatomical and visual outcomes following different anti-vascular endothelial growth factor treatments in subretinal neovascular membrane secondary to type 2 proliferative macular telangiectasia.
Karasu B; Gunay BO
Graefes Arch Clin Exp Ophthalmol; 2020 Jan; 258(1):99-106. PubMed ID: 31768680
[TBL] [Abstract][Full Text] [Related]
3. Outcomes of Anti-vascular Endothelial Growth Factor Treatment for Foveal Serous Retinal Detachment Associated with Inferior Staphyloma.
Lee EK; Yu HG
Korean J Ophthalmol; 2019 Jun; 33(3):228-237. PubMed ID: 31179654
[TBL] [Abstract][Full Text] [Related]
4. Progression of macular atrophy in patients undergoing anti-vascular endothelial growth factor therapy for neovascular age-related macular degeneration.
Cho HJ; Park SM; Kim J; Nah SK; Lee J; Lee DW; Kim JW
Acta Ophthalmol; 2021 Jun; 99(4):e540-e546. PubMed ID: 32996674
[TBL] [Abstract][Full Text] [Related]
5. Imaging retinal inflammatory biomarkers after intravitreal steroid and anti-VEGF treatment in diabetic macular oedema.
Vujosevic S; Torresin T; Bini S; Convento E; Pilotto E; Parrozzani R; Midena E
Acta Ophthalmol; 2017 Aug; 95(5):464-471. PubMed ID: 27775223
[TBL] [Abstract][Full Text] [Related]
6. OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY CHANGES IN EARLY TYPE 3 NEOVASCULARIZATION AFTER ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR TREATMENT.
Miere A; Querques G; Semoun O; Amoroso F; Zambrowski O; Chapron T; Capuano V; Souied EH
Retina; 2017 Oct; 37(10):1873-1879. PubMed ID: 28079756
[TBL] [Abstract][Full Text] [Related]
7. Outcomes in Retinal Vein Occlusions Presenting with Poor Visual Acuity Treated with Anti-Vascular Endothelial Growth Factor Therapy: Prognosis and Predictive Factors.
Light JG; Tian J; Wenick AS
Ophthalmol Retina; 2021 Sep; 5(9):888-900. PubMed ID: 33227561
[TBL] [Abstract][Full Text] [Related]
8. MEASUREMENTS OF RETINAL FLUID BY OPTICAL COHERENCE TOMOGRAPHY LEAKAGE IN DIABETIC MACULAR EDEMA: A Biomarker of Visual Acuity Response to Treatment.
Santos AR; Alves D; Santos T; Figueira J; Silva R; Cunha-Vaz JG
Retina; 2019 Jan; 39(1):52-60. PubMed ID: 29077605
[TBL] [Abstract][Full Text] [Related]
9. Intravitreal anti-VEGF treatment for subretinal neovascularisation secondary to type 2 idiopathic juxtafoveolar telangiectasia.
Barth T; Zeman F; Helbig H; Gamulescu MA
Int Ophthalmol; 2018 Feb; 38(1):191-198. PubMed ID: 28108904
[TBL] [Abstract][Full Text] [Related]
10. Non-proliferative type II macular telangiectasia variant with subfoveal detachment: role of anti-VEGF therapy.
Manayath GJ; Ranjan R; Nagesha CK; Narendran V
Br J Ophthalmol; 2020 Sep; 104(9):1216-1222. PubMed ID: 31791941
[TBL] [Abstract][Full Text] [Related]
11. The association of exudation pattern with anatomical and functional outcomes in patients with Neovascular Age-Related Macular Degeneration.
Inan S; Polat O; Karadas M; Inan UU
Rom J Ophthalmol; 2019; 63(3):238-244. PubMed ID: 31687625
[No Abstract] [Full Text] [Related]
12. Relationship Between Final Visual Acuity and Optical Coherence Tomography Findings in Patients with Diabetic Macular Edema Undergoing Anti-VEGF Therapy.
Eraslan S; Yıldırım Ö; Dursun Ö; Dinç E; Orekici Temel G
Turk J Ophthalmol; 2020 Jun; 50(3):163-168. PubMed ID: 32631004
[TBL] [Abstract][Full Text] [Related]
13. Progression of vascular changes in macular telangiectasia type 2: comparison between SD-OCT and OCT angiography.
Pauleikhoff D; Gunnemann F; Book M; Rothaus K
Graefes Arch Clin Exp Ophthalmol; 2019 Jul; 257(7):1381-1392. PubMed ID: 31093765
[TBL] [Abstract][Full Text] [Related]
14. Intravitreal bevacizumab for foveal detachment in idiopathic perifoveal telangiectasia.
Maia OO; Bonanomi MT; Takahashi WY; Nascimento VP; Takahashi BS
Am J Ophthalmol; 2007 Aug; 144(2):296-9. PubMed ID: 17659962
[TBL] [Abstract][Full Text] [Related]
15. Optical Coherence Tomography Angiography Analysis of the Foveal Avascular Zone and Macular Vessel Density After Anti-VEGF Therapy in Eyes With Diabetic Macular Edema and Retinal Vein Occlusion.
Ghasemi Falavarjani K; Iafe NA; Hubschman JP; Tsui I; Sadda SR; Sarraf D
Invest Ophthalmol Vis Sci; 2017 Jan; 58(1):30-34. PubMed ID: 28114569
[TBL] [Abstract][Full Text] [Related]
16. Foveal Microvascular Integrity Association With Anti-VEGF Treatment Response for Diabetic Macular Edema.
Huang WH; Lai CC; Chuang LH; Huang JC; Wu CH; Lin YT; Yeung L
Invest Ophthalmol Vis Sci; 2021 Jul; 62(9):41. PubMed ID: 34323921
[TBL] [Abstract][Full Text] [Related]
17. Fluorescein Angiography Versus Optical Coherence Tomography Angiography in Macular Telangiectasia Type I Treated With Bevacizumab Therapy.
Yannuzzi NA; Gregori NZ; Roisman L; Gupta N; Goldhagen BE; Goldhardt R
Ophthalmic Surg Lasers Imaging Retina; 2017 Mar; 48(3):263-266. PubMed ID: 28297041
[TBL] [Abstract][Full Text] [Related]
18. CORRELATION OF SUBRETINAL HYPERREFLECTIVE MATERIAL MORPHOLOGY AND VISUAL ACUITY IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION.
Kumar JB; Stinnett S; Han JIL; Jaffe GJ
Retina; 2020 May; 40(5):845-856. PubMed ID: 31305505
[TBL] [Abstract][Full Text] [Related]
19. FOVEAL MÜLLER CELL CONE AS A PROGNOSTIC OPTICAL COHERENCE TOMOGRAPHY BIOMARKER FOR INITIAL RESPONSE TO ANTIVASCULAR ENDOTHELIAL GROWTH FACTOR TREATMENT IN CYSTOID DIABETIC MACULAR EDEMA.
Choi M; Yun C; Oh JH; Kim SW
Retina; 2022 Jan; 42(1):129-137. PubMed ID: 34334704
[TBL] [Abstract][Full Text] [Related]
20. Optical Coherence Tomography Angiography of DME and Its Association with Anti-VEGF Treatment Response.
Lee J; Moon BG; Cho AR; Yoon YH
Ophthalmology; 2016 Nov; 123(11):2368-2375. PubMed ID: 27613201
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
